Apo E genotype, diabetes, and peripheral arterial disease in older men: The Honolulu Asia-aging study

Genetic Epidemiology

Volumn 19, Issue 1, 2000, Pages 52-63

  Resnick, Helaine E ^a,d   Rodriguez, Beatriz ^b   Havlik, Richard ^a   Ferrucci, Luigi ^a,c   Foley, Daniel ^a   Curb, J David ^b   Harris, Tamara B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c INRCA   (Italy)

^d MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

Apolipoprotein E; Diabetes; Elderly; Men; Peripheral arterial disease; Smoking

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; AGING; ALLELE; ARTERY DISEASE; ARTICLE; ASIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEINS E; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIABETES MELLITUS; GENE FREQUENCY; GENOTYPE; HAWAII; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; SMOKING;

EID: 0033945004     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2272(200007)19:1<52::AID-GEPI4>3.0.CO;2-M     Document Type: Article

References (21)

1. Boemi M, Sirolla C, Amadio L, Fumelli P, Pometta D, James RW. 1995. Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care 18:504-8.
2. Boer JMA, Feskens EJM, Schouten EG, Havekes LM, Seidell JC, Kromhout D. 1998. Lipid profiles reflecting high and low risk for coronary heart disease:contribution of apolipoprotein E polymorphism and lifestyle. Athersclerosis 136:395-402.
3. Cauley JA, Eichner JE, Kamboh MI, Ferrell RE, Kuller LH. 1993. Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women. Gen Epidemiol 10:27-34.
4. Curb JD, Masaki K, Rodriguez BL, Abbott RD, Burchfiel CM, Chen R, Petrovich H, Sharp D, Yano K. 1995. Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol 15:1495-500.
5. Davignon J, Gregg, RE, Sing CF. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21.
6. Eichner JE, Kuller LH, Orchard TY, Grandits GA, McCallum LM, Ferrell RE, Naton JD. 1993. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 71:160-5.
7. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 1997. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-97.
8. Haviland MB, Lussier-Cacan S, Davignon J, Sing CF. 1995. Impact of apolipoprotein E genotype variation on means, variances and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenerians. Am J Med Gen 58:315-31.
9. Hixson JE, Vernier DT. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-8.
10. Kagan A, Harris BR, Winkelstein W, Johnson KG, Kato H, Syme SL, Rhoads GG, Gay ML, Nichaman MZ, Hamilton HB, Tillotson J. 1974. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristic. J Chron Dis 27:345-64.
11. O'Neal DN, Lewicki J, Ansari MZ, Matthews PG, Best JD. 1998. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. Atherosclerosis 136:1-8.
12. Orchard TJ, Strandness DE. 1993. Assessment of peripheral vascular disease in diabetes: report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association. Circulation 88:819-28.
13. Palumbo PJ, O'Fallon WM, Osbundson PJ, Zimmerman BR, Lanworthy AL, Kazimer FJ. 1991. Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive? Arch Int Med 151:717-21.
14. Pyorala K, Laakso M, Uusitupa M. 1987. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Met Rev 3:463-524.
15. Rodriguez BL, Curb JD, Burchfiel CM, Huang B, Sharp DS, Lu GY, Fujimoto W, Yano K. 1996. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Diabetes Care; 19:587-90.
16. Sing CF, Davignon J. 1985. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Gen 37:268-85.
17. Sing CF, Moll PP. 1989. Genetics of variability of CHD risk. Int J Epidemiol 18:8183-95.
18. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. 1995. Apo E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91:265-9.
19. Ukkola O, Kervinen K, Salmela PI, von Dickhoff K, Laakso M, Kesaniemi A. 1993. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 101:9-15.
20. Vogt MT, Cauley JA, Kuller LH. 1997. Apolipoprotein E phenotype, arterial disease, and mortality among older women: The Study of Osteoporotic Fractures. Gen Epidemiol 14:147-56.
21. Worth RM, Kagan A. 1970. Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. J Chronic Dis 23:389-97.